Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens.

Cancer cytopathology - 25 Apr 2011

Billah Shahreen, Stewart John, Staerkel Gregg, Chen Su, Gong Yun, Guo Ming

Abstract excerpt

BACKGROUND: The aim of this study was to validate clinical utilization of routinely prepared cytology specimens for molecular testing to detect EGFR or KRAS mutations in lung cancer. METHODS: From September 2009 to April 2010, the authors collected 209 cytology specimens from patients with lung cancer at the MD Anderson Cancer Center Department of Pathology. The specimens included 99 cases of endobronchial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Fine-Needle
Share to Body Fluids
Share to Cytological Techniques

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Tomography, X-Ray Computed

Share to Ultrasonography

Source

Identifiers

PMID: 21400670
DOI: 10.1002/cncy.20151

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens.PMID 21400670Read ↗

Use of Exfoliative Specimens and Fine-Needle Aspiration Smears for Mutation Testing in Lung Adenocarcinoma.Semantic proximity Read ↗

A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates.Semantic proximity Read ↗

Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Liquid-based cytology specimens for next-generation sequencing in lung adenocarcinoma: challenges and evaluation of targeted therapy.Semantic proximity Read ↗

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer.Semantic proximity Read ↗

Evaluation of EGFR mutation status in cytology specimens: an institutional experience.Semantic proximity Read ↗

EGFR analysis on scrapings from cytology smears in lung carcinoma, an effective alternative to testing on trucut biopsies.Semantic proximity Read ↗

[Detection of EGFR and K-ras mutations in non-small cell lung cancer using cytological specimens].Semantic proximity Read ↗

EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.Semantic proximity Read ↗

Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer.Semantic proximity Read ↗

Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.Semantic proximity Read ↗

Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.